Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a rare type of B-cell Non-Hodgkin lymphoma (NHL) affecting predominantly male patients. While complete remissions following first-line treatment are frequent, most patients ultimately relapse, with a usually aggressive further disease course. The use of cytarabine-compr...

詳細記述

書誌詳細

出版年:	Cells
主要な著者:	Alexander D. Heini, Ulrike Bacher, Naomi Porret, Gertrud Wiedemann, Myriam Legros, Denise Stalder Zeerleder, Katja Seipel, Urban Novak, Michael Daskalakis, Thomas Pabst
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2022-09-01
主題:	mantle cell lymphoma (MCL) CAR T expansion relapse glofitamab
オンライン･アクセス:	https://www.mdpi.com/2073-4409/11/17/2747